JNK Signalling: A Possible Target to Prevent Neurodegeneration

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|18|1875-1886

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.18, 2007-06, pp. : 1875-1886

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AD vaccine fails to prevent neurodegeneration

By  

Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

The JNK pathway as a therapeutic target for diabetes

By Kaneto Hideaki  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 581-592

Informa Healthcare

Access to resources Recommend Favorite

The Role of JNK Signalling in Responses to Oxidative DNA Damage

By  

Current Drug Targets, Vol. 17, Iss. 2, 2016-02 ,pp. : 154-163

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Endoplasmic Reticulum Stress: An Opportunity to Prevent Neurodegeneration?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 4, 2015-05 ,pp. : 518-533

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 1, 2005-01 ,pp. : 11-26

Bentham Science Publishers

Access to resources Recommend Favorite